Skip to main content
S. 3257 117th Congress Senate

A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the…

Official title: A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after… Show full official titleShow less

Official title: A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

Introduced: November 18, 2021 Introduced by: Jeanne Shaheen Democratic · New Hampshire See on congress.gov
Crime and Law Enforcement
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2021
Read twice and referred to the Committee on the Judiciary.
Nov 18, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 18, 2021

Read twice and referred to the Committee on the Judiciary.

 Plain-English summary Congressional Research Service

This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.

 Related & companion bills 1
  • HR 5950 Improving Patient Access to Care and Treatment Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Capito, Shelley Moore
West Virginia · Nov 18, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3257: A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.. 117th Congress. Open America. https://openamerica.io/bill/117-S-3257/
MLA
"S. 3257: A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3257/.
Bluebook (legal)
S. 3257, 117th Cong. (2026), https://openamerica.io/bill/117-S-3257/.
Markdown link
[S. 3257: A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.](https://openamerica.io/bill/117-S-3257/)
Report a problem